Back to Search
Start Over
Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis
- Source :
- JAMA Facial Plastic Surgery. 21:244-251
- Publication Year :
- 2019
- Publisher :
- Mary Ann Liebert Inc, 2019.
-
Abstract
- IMPORTANCE: In the last decade, there has been a significant increase in the number of practitioners administering botulinum toxin for facial synkinesis. However, there are few resources available to guide treatment patterns, and little is known about how these patterns are associated with functional outcomes and quality of life. OBJECTIVE: To evaluate botulinum treatment patterns, including the dosing and frequency of muscle targeting, for treatment of facial synkinesis and to quantify patient outcomes. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study of 99 patients treated for facial synkinesis was conducted from January 2016 through December 2018 at the Vanderbilt Bill Wilkerson Center in Nashville, Tennessee, a tertiary referral center. INTERVENTION: Onabotulinum toxin A treatment of facial synkinesis. MAIN OUTCOMES AND MEASURES: Patient-reported outcomes on the Synkinesis Assessment Questionnaire and botulinum treatment patterns, including the dosages and frequency of injection for each facial muscle, were compared at the initiation of treatment and at the end of recorded treatment. RESULTS: In total, 99 patients (80 female patients [81%]) underwent botulinum injections for treatment of facial synkinesis. The median (interquartile range) age was 54.0 (43.5-61.5) years, and the median (interquartile range) follow-up was 27.1 (8.9-59.7) months. Most patients underwent injections after receiving a diagnosis of Bell palsy (41 patients, 41%) or after resection of vestibular schwannoma (36 patients [36%]). The patients received a total of 441 treatment injections, and 369 pretreatment and posttreatment Synkinesis Assessment Questionnaire scores were analyzed. The mean botulinum dose was 2 to 3 U for each facial muscle and 9 to 10 U for the platysma muscle. The dose increased over time for the majority of all muscles, with steady state achieved after a median of 3 treatments (interquartile range, 2-3). Linear regression analysis for cluster data of the mean total questionnaire score difference was −14.2 (95% CI, −17.0 to −11.5; P
- Subjects :
- Adult
Male
medicine.medical_specialty
Steady state (electronics)
Synkinesis
Treatment outcome
Facial Muscles
030230 surgery
Injections, Intramuscular
03 medical and health sciences
0302 clinical medicine
Physical medicine and rehabilitation
Humans
Medicine
Botulinum Toxins, Type A
030223 otorhinolaryngology
Original Investigation
business.industry
Middle Aged
medicine.disease
Botulinum toxin
Facial muscles
Treatment Outcome
medicine.anatomical_structure
Neuromuscular Agents
Female
Surgery
business
medicine.drug
Subjects
Details
- ISSN :
- 21686092 and 21686076
- Volume :
- 21
- Database :
- OpenAIRE
- Journal :
- JAMA Facial Plastic Surgery
- Accession number :
- edsair.doi.dedup.....574caed851ea6bafc80966b624b26839
- Full Text :
- https://doi.org/10.1001/jamafacial.2018.1962